Elvitegravir(GS-9137,JTK-303),喹诺酮类HIV整合酶抑制剂

Elvitegravir (GS-9137, JTK-303) (订货以英文为准)

编号:E126129
CAS号:697761-98-1
分子式:C23H23CLFNO5
分子量:447.88
货号 品牌 包装 目录价 您的价格 库存 数量 购买
E126129-10mg 阿拉丁 10mg ¥117.90
E126129-100mg 阿拉丁 100mg ¥671.90
E126129-50mg 阿拉丁 50mg ¥395.90
产品名称 Elvitegravir (GS-9137, JTK-303)
中文名称 Elvitegravir(GS-9137,JTK-303),喹诺酮类HIV整合酶抑制剂
CAS号 697761-98-1
分子式(M.F.) C23H23CLFNO5
分子量(M.W.) 447.88
储存条件 2-8°C储存
溶解性DMSO ≥86mg/mL Water <1.2mg/mL Ethanol ≥85mg/mL
存贮条件储存温度 2-8°C
应用An HIV-1 integrase inhibitor
产品介绍Elvitegravir (GS-9137, JTK-303)是人免疫缺陷病毒整合酶抑制剂,作用于HIV-1 IIIB, HIV-2 EHO和HIV-2 ROD时,IC50分别为0.7,2.8和1.4 nM。
备注Elvitegravir (EVG, JTK-303/GS-9137) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively.
生化机理Elvitegravir is an inhibitor of HIV-1 integrase which is responsible for the strand-transfer step of integration. Studies indicate that Elvitegravir is effective against HIV-1 strains that are resistant to other agents such as nucleotide reverse-transcriptase inhibitors (NRTIs), nonnucleoside reverse-transcriptase inhibitors (NNRTIs), and protease inhibitors (PIs), as a result of Elvitegravir's ability to block the function of HIV1 integrase.
别名埃替拉韦;GS-9137; JTK-303; EVG; D06677;6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
搜索质检报告(COA)
搜索MSDS
相关产品
CAS号:2098-66-0
¥ 3545.00 C829982-100mg
¥ 200.00 100566-100g
CAS号:87-66-1
¥ 26.00 P-98650+25g-25g
CAS号:53784-84-2
¥ 748.80 X170299A-100mg
CAS号:747-36-4
¥ 100.00 B28598-20mg
CAS号:29667-48-9
¥ 2136.90 M633548-100mg
CAS号:1380005-74-2
¥ 1468.80 X192029A-100mg
CAS号:61349-72-2
¥ 1995.00 1958347-100mg